In a preclinical investigation by Albadrani et al., it was discovered that MC targeted the liver via a NADPH Oxidase 2 (NOX2)–miR21 axis-dependent mechanism, which elevated oxidative stress, generated more peroxynitrite, and exacerbated NAFLD conditions [70]. The gene discussed is CYBB; the disease is metabolic dysfunction-associated steatotic liver disease.